The increase in body mass index observed after lung volume reduction may act as surrogate marker of improved health status  by Oey, Inger F. et al.
The increase in body mass index observed after
lung volume reduction may act as surrogate marker
of improved health status
Inger F. Oey, Sabyasachi Bal, Tom J. Spyt, Michael D.L. Morgan,
David A. Waller*
Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester LE3 9QP, UK
Received 10 March 2003; accepted 16 September 2003
Summary Objective: To assess the effects of lung volume reduction surgery (LVRS) on
body mass index (BMI).
Methods: Prospective data was collected on a series of 63 patients undergoing LVRS
(bilateral in 22 patients, unilateral in 41 patients). Median age was 58 (41–70) years.
The peri-operative effects of LVRS on BMI, lung function and health status (assessed
by SF 36 questionnaire) were recorded at 3, 6, 12 and 24 months.
Results: We found an overall increase in BMI after LVRS, which was significant up to
2 years. These changes correlated with the changes in FEV1 (R ¼ 0:3; Po0:01 6 months
after LVRS) and diffusing capacity for carbon monoxide (DLCO) (R ¼ 0:5; Po0:01 6
months after LVRS). At 6 months, when the best results in health status were found,
the patients were divided in a responders group (improved SF 36 score) and a non-
responders group (same or worse SF 36 score) for each of the 8 domains of the SF 36.
In 6 domains the non-responders showed no increase in BMI. In 6 domains the
responders showed a significant increase in BMI.
Conclusion: LVRS significantly improves postoperative BMI, which correlates with
improvements in DLCO and reflects changes in health status.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Nutritional depletion has been reported in one-
third of patients with stable COPD1 and when
expressed as percentage of ideal body weight, is
significantly correlated with FEV1 and diffusing
capacity for carbon monoxide (DLCO).2 Under-
weight patients experience a higher degree of
dyspnoea3 and a low body mass index (BMI) is
associated with increased risk of mortality.4
The observed weight loss in COPD is the result of
a decrease in body cell mass. Muscle mass is the
largest component of body cell mass and is
indirectly measured as fat-free mass. In addition
emphysematous patients not only have a lower fat-
free mass but also a lower fat mass compared to
chronic bronchitis patients.5 There have been
conflicting results from studies regarding the effect
of nutritional supplementation in patients with
COPD but a meta-analysis found that nutritional
supplementation did not have any effect on
pulmonary function, body weight or BMI.6 In
contrast, several surgical series have reported an
increase in weight after lung volume reduction
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surgery (LVRS).7–9 One study showed this to be due
to an increase in fat-free mass.8
Lung volume reduction has also been shown to
result in improvements in respiratory physiology
and health status.10,11 We wanted to test the
hypothesis that increased BMI after LVRS correlates
with improved pulmonary function and more
importantly with the observed improvement in
health status.
Patients and methods
All patients referred for LVRS were assessed by a
multi-disciplinary selection panel comprising: a
respiratory physician, a physiotherapist, two radi-
ologists and two surgeons. Patients underwent
physical examination including measurements of
weight and height, basic spirometry, plethysmo-
graphy, arterial blood gas analysis, chest radio-
graphy, computed tomography and radionuclide
ventilation/perfusion scintigraphy.
Selection criteria
Patients had to have significant symptomatic
dysfunction judged by the modified MRC dyspnoea
scale as grade 3–5.12 Spirometric inclusion criteria
consisted of an FEV1 of 15–40% of predicted;
residual volume (RV) in excess of 200% of predicted;
total lung capacity (TLC) greater than 120% of
predicted and a RV/TLC ratio over 60%. Anatomical
criteria included the presence of heterogeneous
emphysema with target areas of severe emphysema
on CT scan. ‘‘Physiological’’ heterogeneity was
assessed on radionuclide scintigraphy. This was
quantitated by calculating the ‘‘Q score’’ as
determined by the ratio of perfusion in the target
zone to the total lung perfusion.13,14 Patients with
target areas in either upper or lower lobes were
included.
Exclusion criteria included single large bullae,
hypercapnia (pCO2 greater than 7 kPa), greatly
reduced diffusion capacity (KCO less than 25% of
predicted).
All patients underwent preoperative pulmonary
rehabilitation. Patients who could not complete a
distance of 150m in a shuttle walk test did not
proceed to operation. Rehabilitation was carried
out as a 7-week out-patient or 2-week in-patient
programme.
Before surgery but after rehabilitation, health
status was assessed using the Medical Outcomes
Survey Short Form 36-item questionnaire (SF 36).15
This is a generic health status questionnaire in
which 36 questions covers 8 health domains;
physical functioning, social functioning, role lim-
itations due to physical problems, role limitations
due to emotional problems, mental health, energy/
vitality, pain and general health status. For each
domain scores are transformed to range from 0
(worst possible health status) to 100 (best possible
health status).
Surgical approach
At the start of the series all operations were
performed bilaterally via median sternotomy. Sub-
sequently one of the surgeons adopted a policy of
bilateral video-assisted thoracoscopic surgery
(VATS) and latterly a policy of staged unilateral
VATS. All operations entailed stapled resection of
functionless areas of lung using bovine pericardial
buttresses (Peri Strips, Bio-Vascular, MN) as de-
scribed previously.10
Postoperative follow-up
Patients were reviewed as outpatient clinic at 3, 6,
12 and 24 months post-LVRS. Patients underwent
detailed spirometry and plethysmography. DLCO
was measured by single-breath technique (assumed
normal haemoglobin). Weight (indoor clothes) and
height were recorded routinely to determine the
normal values of physiological measurements for
each patient. All values of respiratory physiology
are given as percent of predicted normal values. At
each visit patients completed SF 36 questionnaires.
Statistical analysis
The relationships between preoperative and post-
operative variables were assessed using paired and
unpaired Student’s t-test. Correlations were deter-
mined using Pearson correlation coefficient. A P-
value less than 0.05 was considered to indicate a
statistically significant difference.
Results
Preoperative characteristics
Prospective data was collected of 75 patients.
Patients who had not yet reached 3 months post
surgery (3 patients) or who had died (9 patients)
before the 3 months follow-up were excluded from
this series. Data was available for 63 patients at 3
months, 58 patients at 6 months, 47 patients at 12
months and for 35 patients at 24 months. The
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reason data was not available for the remaining
patients was that patients had either not reached
the relevant time interval, were lost to follow-up (3
cases, 2 at 12 and 1 at 24 months) or had died (1
patient died between 3 months and 6 months
follow-up).
Median age was 58 years (range 41–70 years).
There were 38 male and 25 female patients.
Twenty-two patients underwent bilateral LVRS, 8
by VATS and 14 by median sternotomy. 41 patients
had unilateral VATS.
Postoperative change in pulmonary function
There was a significant postoperative improvement
in FEV1, TLC and RV lasting for at least 2 years post
surgery (Table 1).
Postoperative change in health status
The best SF 36 scores were obtained 6 months after
surgery (Fig. 1). At this time interval there was a
statistically significant overall improvement in SF
36 scores in 7 out of the 8 health domains. The pain
score at 6 months was still lower than the
preoperative score.
As the influence of LVRS on each of the 8 domains
of the SF 36 questionnaire is different we looked in
each health domain how many patients improved
their scores after surgery (responders (group R))
and how many showed no improvement or a worse
score (non-responders (group NR)).
The relative distribution between the two groups
varied according to health domain with the biggest
group R in the domain of physical function (79% of
patients with improved score) and the smallest
group R in the pain domain (26% of patients with
improved score) (Table 2). There was no difference
between the R and NR groups as regard to age,
gender, type of operation, preoperative weight or
distribution of underweight patients.
Postoperative change in weight and body
mass index
Preoperative weight was 63 (14) kg and BMI 22
(4) kg/m2. Twelve patients were nutritional de-
pleted (i.e. BMI less than 19 kg/m2). There was a
postoperative increase in weight and BMI after
LVRS, which was statistically significant from 6
month up to 24 months post surgery (Fig. 2).
There was no statistically significant correlation
between the improvement in hyperinflation and the
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Table 1 Postoperative changes in pulmonary function.
Mean (SD) Preop 3 months postop 6 months postop 12 months postop 24 months postop
No of patients 63 56 54 47 34
FEV1 (% pred) 28 (9) 35 (13)
nn 34 (14)nn 35 (14)nn 33 (13)
TLC (% pred) 146 (17) 127 (18)nn 132 (17)nn 133 (20)nn 127 (15)nn
RV (% pred) 267 (58) 208 (51)nn 213 (55)nn 220 (63)nn 221 (56)nn
DLCO (% pred) 45 (12) 45 (13) 47 (14) 45 (15) 47 (16)
nnPo0:01 paired t-test.
Figure 1 Health status assessed by SF 36 improves 6
months after LVRS in all domains except for pain (0%
worse score, 100% best score).
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change in weight or BMI. However, we did find a
significant correlation between the change in
weight and BMI and change in DLCO at 6, 12 and
24 months (Fig. 3). There was a similar correlation
with the changes in FEV1 at 6, 12 and 24 months
(Fig. 4). The best correlation was seen at 6 months.
Group R (Table 2): In six health domains, with the
exceptions of the domains of pain and general
health perception, group R showed significant
increases in weight and BMI as well as DLCO. These
changes in weight and BMI correlated with changes
in DLCO. In these 6 domains the changes in FEV1,
TLC and RV were significant but there was no
correlation between the changes in FEV1 or
hyperinflation and changes in BMI.
Group NR (Table 2): There was a significant
improvement in weight and BMI in the pain and
general health perception domain but not in the
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Table 2 Changes in BMI and their correlation with DLCO in group non-responders (NR) and responders (R).
Health domain Ratio NR/R (%) Change in BMI mean (SD)
(kg/m2)
Correlation with DLCO
Physical functioning NR 21 0.3 (1.3) R ¼ 0:34
R 79 0.6 (1.6)n R ¼ 0:49nn
Social functioning NR 31 0.4 (1.1) R ¼ 0:11
R 69 0.6 (1.6)n R ¼ 0:49n
Role limit physical problems NR 60 0.3 (1.5) R ¼ 0:18
R 40 0.9 (1.4)n R ¼ 0:62nn
Role limit emot problems NR 62 0.4 (1.3) R ¼ 0:35
R 38 0.7 (1.7) R ¼ 0:57n
Mental health NR 33 0.3 (1.0) R ¼ 0:03
R 67 0.7 (1.7)n R ¼ 0:53n
Energy NR 33 0.2 (1.4) R ¼ 0:15
R 67 0.9 (1.4)nn R ¼ 0:45n
Pain NR 74 0.5 (1.6)n R ¼ 0:49nn
R 26 0.5 (1.1) R ¼ 0:15
General health perception NR 38 0.7 (1.3)n R ¼ 0:29
R 62 0.4 (1.6) R ¼ 0:55nn
nPo0.05.
nnPo0.01.
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Figure 2 Postoperative improvements in BMI after LVRS.
nPo0:05; nnPo0:01 compared to preoperative values.
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Figure 3 Correlation between changes in BMI and
changes in DLCO 6 months after LVRS.
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other domains. Although this group showed a
significant reduction in TLC and RV, there was no
significant improvement in DLCO. In four domains a
significant improvement was found in FEV1. There
was no correlation between the changes in BMI and
the changes in DLCO or changes in hyperinflation.
Discussion
LVRS significantly affects BMI, which correlates with
changes in DLCO and may reflect changes in health
status.
Patients with emphysema are frequently nutri-
tionally depleted. However, less is known about the
underlying mechanism. Nutritional depletion can
result from an imbalance between energy intake
and expenditure of energy and/or from an altered
substrate metabolism.16
The improvements in nutritional status after LVRS
may be due to increase in dietary intake. It may be
that patients who feel less dyspnoeic after LVRS are
more likely to eat more as eating causes less
postprandial breathlessness.17 Improvement in
health status may also result in patients to eat
more. There may be a positive influence on diet
intake from dieticians during patients’ hospital
stay. However, although Nezu did find an increase in
dietary intake after LVRS, this did not correlate
with the changes in weight.8 In addition, emphyse-
ma patients who underwent lung transplantation
and who were nutritionally depleted preopera-
tively, also improved their nutritional status post
surgery whilst maintaining their preoperative ca-
loric intake.18
Another explanation of the observed improve-
ment in weight is decreased resting energy ex-
penditure. Takayama found reduced energy
expenditure of the respiratory muscles, correlating
with the improvements in hyperinflation and small
airway obstruction observed after LVRS.19 The
increase in fat-free mass would also results in a
more effective respiratory muscle function. Mineo
did find a significant correlation between RV and
the increase in weight after LVRS.9 However,
Christensen also found no correlation between
TLC or RV and the changes in weight.7 Baarends
found that patients with COPD had an increased
activity-related energy expenditure.20 As patients
gain fat-free mass after LVRS there may be a more
efficient use of muscle mass resulting in decreased
activity-related energy expenditure.
Loss of skeletal muscle mass has also been
attributed to inflammatory mediators such as
tumour necrosis factor a (TNF-a) and interleukins.21
In addition patients will develop an inflammatory
response to their operation. Drugs as corticoster-
oids and smoking will modify this inflammatory
response. The difference between the R and NR
group may be related to a different inflammatory
status. One study similarly showed that some
underweight emphysematous patients did and some
patients did not respond to nutritional therapy. This
non-response was correlated with an elevated
systemic inflammatory response.22
Any explanation of the improved BMI after LVRS
has to include the observed correlation with the
changes in DLCO. Oxygen delivery may play a role
in weight gain. Christensen’s study looked into
more detail in the possible mechanisms.7 The
hypothesis that this was due to increased haemo-
globin secondary to the improved nutritional status
could not be confirmed as they observed a decrease
rather than an increase in haemoglobin after LVRS.
It was also suggested that DLCO improved due to
opening of pulmonary vessels but there was no
change in the postoperative KCO. The loss of fat-
free mass in emphysematous patients has been
linked to an altered protein metabolism. A con-
sistent finding is the reduction in muscle gluta-
mate, which has been associated with a reduction
in diffusing capacity.23
There is an influence of nutrition depletion on
health status in patients with emphysema. Dys-
pnoea, reduced exercise capacity and reduced fat-
free mass are thought to be related to health
status.24 Sahebjami found that underweight pa-
tients were more dyspnoeic than normal weight
patients and that DCLO was a predictor of the
dyspnoea intensity.3
The majority of our analysis is performed at 6
months post LVRS. The greatest improvement in
health status (as measured with the SF 36 ques-
tionnaire) is at 6 months. After 6 months there is a
steady decline in health status. This may represent
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Figure 4 Correlation between changes in BMI and
changes in FEV1 6 months after LVRS.
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natural progression of the disease. The maximum
increase in BMI occurs at 1 year, whilst pulmonary
function starts declining after 3–6 months. The
correlation between increase in BMI and DLCO
might be greater if maximum BMI increase and
maximum DLCO improvement were correlated even
though they were measured at different time
points.
We used the SF 36 questionnaire rather than a
disease-specific instrument so that we could mea-
sure the impact of LVRS on the wider aspects of
health status. Mahler’s evaluation of the SF 36 in
patients with COPD found it to be a valid instru-
ment to measure health status in these patients,
although as yet it is not known what change in score
consists of a clinical significant change.25
One problem in comparing studies on nutrition is
that nutritional status is being defined in various
different ways. We only used weight and BMI as
parameter of nutrition. Although antropometric
measurements and measurement of fat-free mass
may be more accurate, weight and BMI is a more
practical tool for assessing patients preoperatively
and in out-patient clinics. In addition, it is BMI that
has been linked to prognosis.4
Not only does nutritional depletion have an
impact on the degree of dyspnoea and possibly
health status, it is also a risk factor for post-
operative complications after LVRS.26,27
In this limited observational study we have found
that successful LVRS is associated with improve-
ment in nutritional status. Although we have not
been able to explain the exact mechanism for this,
it is reasonable to assume that performing LVRS
has some positive benefit since simple nutri-
tional supplementation is not associated with such
improvement.
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